Portal de investigação
Efficacy and Safety of Empagliflozin in Hospitalized Heart Failure Patients: Main Results From the EMPULSE Trial
Autores da FMUP
Participantes de fora da FMUP
- Voors, AA
- Angermann, CE
- Teerlink, JR
- Collins, SP
- Kosiborod, MN
- Biegus, J
- Nassif, ME
- Psotka, MA
- Tromp, J
- Brueckmann, M
- Blatchford, J
- Salsali, A
- Ponikowski, P
Unidades de investigação
Abstract
Abstract no disponible
Filiações
Filiações não disponíveis
Keywords
- Acute heart failure; Drugs; Heart failure; Quality of life
Proyectos asociados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
Citar a publicação
Voors,AA,Angermann,CE,Teerlink,JR,Collins,SP,Kosiborod,MN,Biegus,J,Ferreira,JP et al. Efficacy and Safety of Empagliflozin in Hospitalized Heart Failure Patients: Main Results From the EMPULSE Trial. Annual Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium. 2021. Boston. TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA:Lippincott Williams and Wilkins Ltd. 2021 p.p. 572-572.
